Similarly, high expression of BIRC5 was associated with overall survival in breast cancer, clear-cell renal cell carcinoma, gastric cancer, and lung cancer (Ni et al., 2019; Wan et al., 2019; Zou et al., 2019; Dai et al., 2020). Here, BIRC5 is linked to lung cancer.